Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Total 13F shares
-
976,890
-
Share change
-
+713,406
-
Total reported value
-
$74,211,074
-
Price per share
-
$75.96
-
Number of holders
-
10
-
Value change
-
+$54,190,686
-
Number of buys
-
5
-
Number of sells
-
1
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q4 2025
As of 31 Dec 2025 PTC THERAPEUTICS, INC. - Common Stock (PTCT) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 976,890 shares of stock of the company.
Largest 10 holders included SG Americas Securities, LLC, Assenagon Asset Management S.A., DIVERSIFIED TRUST CO, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, GAMMA Investing LLC, True Wealth Design, LLC, CVA Family Office, LLC, Versant Capital Management, Inc, Abound Wealth Management, and Rialto Wealth Management, LLC.
This table shows 10 institutional shareholders of the security as of 31 Dec 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.